Culture medium and cell density impact gene expression in normal skin and abnormal scar-derived fibroblasts

Journal of Burn Care and Research

Volumn 32, Issue 4, 2011, Pages 498-508

  McFarland, Kevin L ^a   Glaser, Kathryn ^a   Hahn, Jennifer M ^a   Boyce, Steven T ^a,b   Supp, Dorothy M ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; COLLAGEN TYPE 1 ALPHA 2; INTERSTITIAL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL DENSITY; CELL FUNCTION; CELL PROLIFERATION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERTROPHIC SCAR; INFANT; KELOID; MALE; NEWBORN; PHENOTYPE; SCHOOL CHILD;

ANIMALS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; COLLAGEN TYPE I; CULTURE MEDIA; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; SERUM;

EID: 79960772292     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182223cb1     Document Type: Article

References (61)

1. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006;297:433-8.
2. Van Loey NEE, Van Son MJM. Psychopathology and psychological problems in patients with burn scars. Am J Clin Dermatol 2003;4:245-72.
3. Burd A, Huang L. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 2005;116:150e-7e.
4. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006;117:286-300. (Pubitemid 44391579)
5. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003;4:235-43. (Pubitemid 36506429)
6. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg 1999;25:631-8. (Pubitemid 29383470)
7. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990;43:70-7. (Pubitemid 20111343)
8. Slemp AE, Kirschner RE. Keloids and scars: a review of ke-loids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006;18:396-402. (Pubitemid 44258997)
9. Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994;12:27-37. (Pubitemid 24050735)
10. Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm Venereol 1995;75:102-4.
11. Calderon M, Lawrence WT, Banes AJ. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res 1996; 61:343-7. (Pubitemid 26087681)
12. Tsou R, Cole JK, Nathens AB, et al. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil 2000;21:541-50. (Pubitemid 32050421)
13. Chen W, Fu X, Sun X, Sun T, Zhao Z, Sheng Z. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res 2003;113:208-16. (Pubitemid 37040891)
14. Wu J, Ma B, Yi S, et al. Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays. J Trauma 2004;57:1276-86. (Pubitemid 40053825)
15. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2007;128:1298-310. (Pubitemid 351543197)
16. Seifert O, Bayat A, Geffers R, et al. Identification of unique gene expression patterns within different lesional sites of ke-loids. Wound Repair Regen 2008;16:254-65. (Pubitemid 351342120)
17. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA 1985;82: 5935-9. (Pubitemid 16218877)
18. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993;55:214-22. (Pubitemid 23335800)
19. Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J. Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Der-matol 1994;130:453-9. (Pubitemid 24204663)
20. Zhang K, Garner W, Cohen L, Rodriguez J, Phan S. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 1995;104:750-4.
21. Ghahary A, Shen YJ, Scott PG, Gong Y, Tredget EE. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 1993;122:465-73. (Pubitemid 23346783)
22. Arakawa M, Hatamochi A, Mori Y, Mori K, Ueki H, Mori-guchi T. Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 1996;134: 863-8. (Pubitemid 26151400)
23. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE. Collagenase production is lower in post-burn hypertro-phic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 1996;106: 476-81. (Pubitemid 26117584)
24. Yeh FL, Shen HD, Lin MW, Chang CY, Tai HY, HuangMH. Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2. Burns 2006;32:299-304.
25. Sible JC, Eriksson E, Smith SP, Smith N. Fibronectin gene expression differs in normal and abnormal human wound healing. Wound Repair Regen 1994;2:3-19.
26. Oliver N, Babu M, Diegelmann R. Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol 1992;99:579-86.
27. Russell SB, Russell JD, Trupin KM, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010;130:2489-96.
28. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996;106:1007-11. (Pubitemid 26153504)
29. Tuan TL, Wu H, Huang EY, et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003;162:1579-89. (Pubitemid 36512841)
30. Rifkin DB, Gleizes PE, Harpel J, et al. Plasminogen/ plasminogen activator and growth factor activation. Ciba Found Symp 1997;212:105-15.
31. Wang R, Ghahary A, Shen Q, Scott PG, Roy K, Tredget EE. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000;8:128-37. (Pubitemid 30238326)
32. Liu W, Cai Z, Wang D, et al. Blocking transforming growth factor-beta receptor signaling down-regulates transforming growth factor-beta1 autoproduction in keloid fibroblasts. Chin J Traumatol 2002;5:77-81. (Pubitemid 43026800)
33. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005;153:295-300. (Pubitemid 41228425)
34. Trojanowska M. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr Opin Rheumatol 2009;21:623-9.
35. Verrecchia F, Laboureau J, Verola O, et al. Skin involvement in scleroderma-where histological and clinical scores meet. Rheumatology (Oxford) 2007;46:833-41. (Pubitemid 47061718)
36. Kessler-Becker D, Smola S, Krieg T, Eckes B. High plasminogen activator inhibitor type 2 expression is a hallmark of scleroderma fibroblasts in vitro. Exp Dermatol 2004;13: 708-14. (Pubitemid 39481024)
37. Ala-Kokko L, Rntala A, Savolainen ER Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures J Invest Dermatol 1987;89:238-44. (Pubitemid 17126576)
38. Pinnel SR, Murad S, Darr D. Induction of collagen synthesis by ascorbic acid. A possible mechanism. Arch Dermatol 1987;123:1684-6. (Pubitemid 18012186)
39. Boyce ST, Kagan RJ, Greenhalgh DG, et al. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 2006;60:821-9.
40. Boyce ST, Ham RG. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J Tiss Cult Meth 1985;9:83-93. (Pubitemid 16207732)
41. Bettger WJ, Boyce ST, Walthall BJ, Ham RG. Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone. Proc Natl Acad Sci USA 1981;78:5588-92. (Pubitemid 12245195)
42. Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitz-miller WJ, Supp DM. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol 2005;125:1286-301.
43. Boyce ST. In: Morgan JR, Yarmush ML, editors. Methods for the serum-free culture of keratinocytes and transplantation of collagen-GAG-based skin substitutes. In: Methods in molecular medicine, Vol. 18: Tissue engineering methods and protocols. Totowa, NJ, Humana Press Inc.; 1999;365-89.
44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-AACT method. Methods 2001;25:402-8. (Pubitemid 34164012)
45. Bayreuther K, Rodemann HP, Hommel R, Dittmann K, Al-biez M, Francz PI. Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci USA 1988;85:5112-6.
46. Delany AM, Brinckerhoff CE. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibro-blasts. J Cell Biochem 1992;50:400-10. (Pubitemid 23005807)
47. Hill DJ, Milner RD. Insulin as a growth factor. Pediatr Res 1985;19:879-86. (Pubitemid 15226850)
48. Goldstein RH, Poliks CF, Pilch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endo 1989;124:964-70. (Pubitemid 19057093)
49. Liu Y, Zhang X, Zhang Z, Fang PY, Xu WS. Effects of topical application of insulin on the wound healing in scalded rats. Zhonghua Shao Shang Za Zhi 2004;20:98-101.
50. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987;247:597-604. (Pubitemid 17158405)
51. McGregor GP, Biesalski HK. Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 2006;9:697-703. (Pubitemid 44624616)
52. Berger MM. Vitamin C requirements in parenteral nutrition. Gastroenterology 2009;137(5 Suppl):S70-8.
53. Lima CC, Pereira AP, Silva JR, et al. Ascorbic acid for the healing of skin wounds in rats. Braz J Biol 2009;69: 1195-201.
54. Jagetia GC, Rajanikant GK, Mallikarjun Rao KV. Ascorbic acid increases healing of excision wounds of mice whole body exposed to different doses of gamma-radiation. Burns 2007; 33:484-94. (Pubitemid 46702382)
55. Russell SB, Russell JD, Trupin KM. Collagen synthesis in human fibroblasts: effects of ascorbic acid and regulation by hydrocortisone. J Cell Physiol 1981;109:121-31. (Pubitemid 12231915)
56. Russell JD, Russell SB, Trupin KM. Differential effects of hydrocortisone on both growth and collagen metabolism of human fibroblasts from normal and keloid tissue. J Cell Physiol 1978;97:221-9. (Pubitemid 9095683)
57. Mikus P, Ny T. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J Biol Chem 1996; 271:10048-53. (Pubitemid 26131562)
58. Kessler D, Dethlefsen S, Haase I, et al. Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" pheno-type. J Biol Chem 2001;276:36575-85.
59. Medcalf RL, Stasinopoulos SJ. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J 2005;272:4858-67. (Pubitemid 41415110)
60. Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in trans-genic mice. Cancer Res 2001;61:970-6. (Pubitemid 32174413)
61. Tonnetti L, Netzel-Arnett S, Darnell GA, et al. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res 2008;68:5648-57.